Related Experiment Video
Updated: Oct 3, 2025

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Acute Isolated Thrombocytopenia Secondary to Meloxicam Use: A Case Report
Nardine Abdelsayed1, Michael Frost1, William R Betz1
1Internal Medicine, Grand Strand Medical Center, Myrtle Beach, USA.
Abstract:
Meloxicam is a widely used nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and some inflammatory disorders. One rare side effect is drug-induced thrombocytopenia (DITP), which can result in hemorrhage and death if not treated urgently. This diagnosis can be missed if mistaken for other conditions such as ITP, which is problematic since the mainstay of treatment is medication cessation. We present a case of a 42-year-old Hispanic female who was recently started on meloxicam and presented with petechiae, ecchymosis, and a platelet count of 2 (normal 150-350 K/mm3).
Insights
Meloxicam, a common NSAID, can cause rare drug-induced thrombocytopenia (DITP), a serious condition. Prompt diagnosis and drug cessation are crucial for managing this potentially fatal side effect.
Area of Science:
- Pharmacology
- Hematology
- Internal Medicine
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) like meloxicam are frequently prescribed for pain and inflammation.
- Drug-induced thrombocytopenia (DITP) is a rare but severe adverse reaction to certain medications.
Observation:
- A 42-year-old female developed petechiae and ecchymosis after initiating meloxicam.
- The patient presented with a critically low platelet count of 2 K/mm³.
Findings:
- The clinical presentation and severe thrombocytopenia were consistent with meloxicam-induced DITP.
- Differential diagnosis included immune thrombocytopenia (ITP), highlighting the importance of medication history.
Implications:
- Early recognition of meloxicam-associated DITP is vital to prevent life-threatening hemorrhage.
- Discontinuation of the offending NSAID is the primary treatment for DITP.
- This case underscores the need for vigilance regarding rare NSAID side effects.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Myocarditis III: Medical Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endocarditis III: Medical Management

